Article info

Download PDFPDF
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease

Authors

  1. Correspondence to Amy Patel Jain, Ophthalmology, Cedars-Sinai Medical Center, Los Angeles, CA, USA; amypatel09{at}gmail.com
View Full Text

Citation

Jain AP, Gellada N, Ugradar S, et al
Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease

Publication history

  • Received September 2, 2020
  • Revised October 15, 2020
  • Accepted October 21, 2020
  • First published November 10, 2020.
Online issue publication 
January 21, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.